Avis Estimates Raised and 3 Must-See Stock Analyses

| + More Articles
  • Like on Facebook
  • Share on Google+
  • Share on LinkedIn

Pharmacyclics Inc. (NASDAQ:PCYC): Brean Capital said the pullback in Pharmacyclics Inc. had made it one of the most attractive investment opportunities in its space. They cited positive Phase 3 studies for Ibrutinib, which highlighted its potential as a front line therapy in the next 3-4 years. Shares are Buy rated with an $80 price target.

Avis Budget Group, Inc. (NYSE:CAR): Following their strong third quarter report, Goldman raised Avis Budget Group, Inc.’sĀ estimates and believes the company will beat their 2013 expectations. Shares are Buy rated with a $20 price target.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

JB Hunt Transport Services Inc. (NASDAQ:JBHT): After speaking with management, FBR Capital believes that J.B. Hunt Transport Services Inc.’s new guidance reflects a bullish 2013 outlook in spite of their cautious view on macroeconomic growth. FBR raised their price target for shares from $65 to $70 and keeps an Outperform rating on the name.

Maiden Holdings, Ltd. (NASDAQ:MHLD): After Maiden Holdings, Ltd. reported higher than expected earnings per share, JMP Securities said that their stock has retreated due to concerns over Hurricane Sandy. However, the firm did note that the company has an on-catastrophe book of business, and they think that Maiden Holdings could actually benefit from Sandy’s effects. The firm reiterates an Outperform rating on their stock.

Don’t Miss: Is it Time to Care About CVS?


More Articles About:

To contact the reporter on this story: staff.writers@wallstcheatsheet.com To contact the editor responsible for this story: editors@wallstcheatsheet.com

Yahoo Finance, Harvard Business Review, Market Watch, The Wall St. Journal, Financial Times, CNN Money, Fox Business